It is critical to comply with 21 CFR p11 and the principles of data integrity when working under GxP during drug development and manufacturing.
This presentation introduces a qNMR solution that enables data integrity and management of qNMR methods for the GxP environment.
This on-demand recording is from USP’s qNMR Workshop, held November 17–19, 2020, and features a presentation by Dr. Fabrice Moriaud.
Subject area:
Drug Products & APIs
Objectives (If applicable):
N/A
Target Audience (If applicable):
Analytical chemists
QC staff
QA staff
R&D staff
Regulatory staff